Colgate-Palmolive Company CL
86.06
0.74
0.87%
as of 25 Sep
- Market cap
- $68.3B
- P/E
- 33.9×
Follow CL
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Colgate-Palmolive Company (CL) P/E ratio
As of 25 September 2026, Colgate-Palmolive Company (CL) trades at a P/E ratio of 33.9×. Over the past ten years it has ranged from 20.9× (November 2025) to 47.9× (September 2016); the current reading is higher than 78% of that period. That is above the Household & Personal Products industry median of 22.5× and above the Consumer Defensive sector median of 16.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 30.0× | 16.67% |
| FY2024 | 25.8× | (10.99%) |
| FY2023 | 28.9× | (21.76%) |
| FY2022 | 37.0× | 10.92% |
| FY2021 | 33.3× | 22.41% |
| FY2020 | 27.2× | 8.79% |
| FY2019 | 25.0× | 15.66% |
| FY2018 | 21.6× | (34.04%) |
| FY2017 | 32.8× | 37.18% |
| FY2016 | 23.9× | (45.07%) |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 36.1× | 9.69% |
| Mar 2026 | 32.9× | 9.52% |
| Dec 2025 | 30.0× | 34.93% |
| Sep 2025 | 22.3× | (12.30%) |
| 42 more quarters | Free account |
Against its own ten years
Low 20.9×
High 47.9×
Ten-year median
27.3×
Current reading's percentile
78
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| UL Unilever PLC compare | 10.5× |
| KMB Kimberly-Clark Corporation compare | 16.7× |
| CLX The Clorox Company compare | 17.4× |
| KVUE Kenvue Inc. compare | 20.5× |
| PG Procter & Gamble Company (The) compare | 21.6× |
| CHD Church & Dwight Co., Inc. compare | 30.9× |
| CL Colgate-Palmolive Company | 33.9× |
| ELF e.l.f. Beauty compare | 99.5× |
| EL The Estee Lauder Companies Inc. compare | 185× |
| Household & Personal Products industry median | 22.5× |
| Consumer Defensive sector median | 16.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CL
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement